Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 11, Pages 3415-3424
Publisher
Informa UK Limited
Online
2014-07-08
DOI
10.4161/hv.29407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer
- (2014) Ya-Chen Tina Shih et al. BREAST CANCER RESEARCH AND TREATMENT
- Manipulating immune cells for adoptive immunotherapy of cancer
- (2014) Phillip K Darcy et al. CURRENT OPINION IN IMMUNOLOGY
- The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model
- (2014) M Hoyle et al. HEALTH TECHNOLOGY ASSESSMENT
- Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
- (2014) L. Maldonado et al. Science Translational Medicine
- Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors
- (2014) Alexander Eggermont et al. OncoImmunology
- New therapeutic vaccination strategies for the treatment of chronic hepatitis B
- (2014) Jia Liu et al. VIROLOGICA SINICA
- A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer
- (2013) A. Lange et al. EUROPEAN JOURNAL OF CANCER
- Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer
- (2013) Przemysław Holko et al. Expert Review of Anticancer Therapy
- Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis
- (2013) Scott Ramsey et al. HEALTH AFFAIRS
- Reforming the Payment System for Medical Oncology
- (2013) Peter B. Bach JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Delivering High-Quality and Affordable Care Throughout the Cancer Care Continuum
- (2013) Ya-Chen Tina Shih et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Full Disclosure — Out-of-Pocket Costs as Side Effects
- (2013) Peter A. Ubel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- A review of economic impact of targeted oral anticancer medications
- (2013) Chan Shen et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings
- (2013) Anthony Jarkowski et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- International variability in the reimbursement of cancer drugs by publically funded drug programs
- (2012) P. K. Cheema et al. Current Oncology
- Prostate cancer vaccines in clinical trials
- (2012) David M Lubaroff Expert Review of Vaccines
- COST-EFFECTIVENESS OF ALEMTUZUMAB FOR T-CELL PROLYMPHOCYTIC LEUKEMIA
- (2012) Lanting Lu et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
- (2012) Alexander M.M. Eggermont et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost Effectiveness of Rituximab for Non-Hodgkinʼs Lymphoma
- (2012) Philipp W.P. Auweiler et al. PHARMACOECONOMICS
- Pharmaco-economic aspects of Sipuleucel-T
- (2012) Steven Simoens Human Vaccines & Immunotherapeutics
- Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis
- (2012) Victor Barzey et al. JOURNAL OF MEDICAL ECONOMICS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer Immunotherapy Comes of Age
- (2011) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent advances in the therapy of castration-resistant prostate cancer: The price of progress
- (2011) Dhwanishiva Vasani et al. MATURITAS
- Bending the Cost Curve in Cancer Care
- (2011) Thomas J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?
- (2010) Ya-Chen Tina Shih et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identifying economic evaluations for health technology assessment
- (2010) Julie Glanville et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
- (2010) Robert L. Ferris et al. JOURNAL OF CLINICAL ONCOLOGY
- Wrestling With the High Price of Cancer Care: Should We Control Costs by Individuals' Ability to Pay or Society's Willingness to Pay?
- (2010) Jennifer L. Malin JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs
- (2009) Peter B. Bach NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
- (2008) Robert K. Oldham et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now